載入...
Biomarkers in Amyloid-β Immunotherapy Trials in Alzheimer's Disease
Drug candidates directed against amyloid-β (Aβ) are mainstream in Alzheimer's disease (AD) drug development. Active and passive Aβ immunotherapy is the principle that has come furthest, both in number and in stage of clinical trials. However, an increasing number of reports on major difficultie...
Na minha lista:
| Main Authors: | , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Nature Publishing Group
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3857643/ https://ncbi.nlm.nih.gov/pubmed/23799530 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/npp.2013.154 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|